
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
LRRK2 and the Endolysosomal System in Parkinson’s Disease
Madalynn L. Erb, Darren J. Moore
Journal of Parkinson s Disease (2020) Vol. 10, Iss. 4, pp. 1271-1291
Open Access | Times Cited: 81
Madalynn L. Erb, Darren J. Moore
Journal of Parkinson s Disease (2020) Vol. 10, Iss. 4, pp. 1271-1291
Open Access | Times Cited: 81
Showing 26-50 of 81 citing articles:
Enhancement of D1 dopaminergic responses in aged LRRK2 G2019S knock-in mice
Daniela Mercatelli, Alberto Brugnoli, Anna Maio, et al.
Neurobiology of Disease (2025), pp. 106881-106881
Open Access
Daniela Mercatelli, Alberto Brugnoli, Anna Maio, et al.
Neurobiology of Disease (2025), pp. 106881-106881
Open Access
Immune cell metabolic dysfunction in Parkinson’s disease
Julian R Mark, Malú G. Tansey
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
Julian R Mark, Malú G. Tansey
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
Roles of LRRK2 and its orthologs in protecting against neurodegeneration and neurodevelopmental defects
An Phu Tran Nguyen, Linh Thi Nhat Nguyen, Bodil Stokke, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
An Phu Tran Nguyen, Linh Thi Nhat Nguyen, Bodil Stokke, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Cannabidiol Induces Autophagy to Protects Neural Cells From Mitochondrial Dysfunction by Upregulating SIRT1 to Inhibits NF-κB and NOTCH Pathways
Shaolei Kang, Jinglin Li, Zhihui Yao, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 27
Shaolei Kang, Jinglin Li, Zhihui Yao, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 27
Recent Advances in the Treatment of Genetic Forms of Parkinson’s Disease: Hype or Hope?
Francesco Cavallieri, Rubens Gisbert Cury, Thiago Gonçalves Guimarães, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 764-764
Open Access | Times Cited: 10
Francesco Cavallieri, Rubens Gisbert Cury, Thiago Gonçalves Guimarães, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 764-764
Open Access | Times Cited: 10
A STING-CASM-GABARAP Pathway Activates LRRK2 at Lysosomes
Amanda Bentley‐DeSousa, Agnes Roczniak-Ferguson, Shawn M. Ferguson
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 10
Amanda Bentley‐DeSousa, Agnes Roczniak-Ferguson, Shawn M. Ferguson
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 10
Prediction of Parkinson’s disease pathogenic variants using hybrid Machine learning systems and radiomic features
Ghasem Hajianfar, Samira Kalayinia, Mahdi Hosseinzadeh, et al.
Physica Medica (2023) Vol. 113, pp. 102647-102647
Open Access | Times Cited: 9
Ghasem Hajianfar, Samira Kalayinia, Mahdi Hosseinzadeh, et al.
Physica Medica (2023) Vol. 113, pp. 102647-102647
Open Access | Times Cited: 9
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Sheila K. Pirooznia, Liana S. Rosenthal, Valina L. Dawson, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1204-1268
Open Access | Times Cited: 21
Sheila K. Pirooznia, Liana S. Rosenthal, Valina L. Dawson, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1204-1268
Open Access | Times Cited: 21
Modeling Parkinson's disease in LRRK2 mice: focus on synaptic dysfunction and the autophagy-lysosomal pathway
Federica Albanese, Chiara Domenicale, Mattia Volta, et al.
Biochemical Society Transactions (2022) Vol. 50, Iss. 1, pp. 621-632
Closed Access | Times Cited: 15
Federica Albanese, Chiara Domenicale, Mattia Volta, et al.
Biochemical Society Transactions (2022) Vol. 50, Iss. 1, pp. 621-632
Closed Access | Times Cited: 15
Leucine-rich repeat kinase 2 at a glance
Christiane Zhu, Susanne Herbst, Patrick A. Lewis
Journal of Cell Science (2023) Vol. 136, Iss. 17
Open Access | Times Cited: 9
Christiane Zhu, Susanne Herbst, Patrick A. Lewis
Journal of Cell Science (2023) Vol. 136, Iss. 17
Open Access | Times Cited: 9
Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase dependent mechanism
Bernd K. Gilsbach, Franz Y. Ho, Benjamin Riebenbauer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Bernd K. Gilsbach, Franz Y. Ho, Benjamin Riebenbauer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
LRRK2 signaling in neurodegeneration: two decades of progress
Lucia Iannotta, Elisa Greggio
Essays in Biochemistry (2021) Vol. 65, Iss. 7, pp. 859-872
Closed Access | Times Cited: 18
Lucia Iannotta, Elisa Greggio
Essays in Biochemistry (2021) Vol. 65, Iss. 7, pp. 859-872
Closed Access | Times Cited: 18
Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease Patients
Dong Chen, Chandrashekhar Honrao, Leonardo O. Rodrigues, et al.
Metabolites (2022) Vol. 12, Iss. 2, pp. 149-149
Open Access | Times Cited: 13
Dong Chen, Chandrashekhar Honrao, Leonardo O. Rodrigues, et al.
Metabolites (2022) Vol. 12, Iss. 2, pp. 149-149
Open Access | Times Cited: 13
Motor Impairments and Dopaminergic Defects Caused by Loss of Leucine-Rich Repeat Kinase Function in Mice
Guodong Huang, Daniel W. Bloodgood, Jongkyun Kang, et al.
Journal of Neuroscience (2022) Vol. 42, Iss. 23, pp. 4755-4765
Open Access | Times Cited: 13
Guodong Huang, Daniel W. Bloodgood, Jongkyun Kang, et al.
Journal of Neuroscience (2022) Vol. 42, Iss. 23, pp. 4755-4765
Open Access | Times Cited: 13
Rab GTPases in Parkinson's disease: a primer
Antonio Jesús Lara Ordóñez, Rachel Fasiczka, Yahaira Naaldijk, et al.
Essays in Biochemistry (2021) Vol. 65, Iss. 7, pp. 961-974
Open Access | Times Cited: 16
Antonio Jesús Lara Ordóñez, Rachel Fasiczka, Yahaira Naaldijk, et al.
Essays in Biochemistry (2021) Vol. 65, Iss. 7, pp. 961-974
Open Access | Times Cited: 16
Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases
María Izco, Estefanía Carlos, Lydia Álvarez-Erviti
Neurobiology of Disease (2022) Vol. 166, pp. 105651-105651
Open Access | Times Cited: 12
María Izco, Estefanía Carlos, Lydia Álvarez-Erviti
Neurobiology of Disease (2022) Vol. 166, pp. 105651-105651
Open Access | Times Cited: 12
LRRK2 and Proteostasis in Parkinson’s Disease
María Dolores Pérez‐Carrión, Inmaculada Posadas, Javier Solera, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6808-6808
Open Access | Times Cited: 12
María Dolores Pérez‐Carrión, Inmaculada Posadas, Javier Solera, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6808-6808
Open Access | Times Cited: 12
Is There a Place for Lewy Bodies before and beyond Alpha-Synuclein Accumulation? Provocative Issues in Need of Solid Explanations
Paola Lenzi, Gloria Lazzeri, Michela Ferrucci, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3929-3929
Open Access | Times Cited: 2
Paola Lenzi, Gloria Lazzeri, Michela Ferrucci, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3929-3929
Open Access | Times Cited: 2
The AAV-α-Synuclein Model of Parkinson’s Disease: An Update
Anders Björklund, Bengt Mattsson
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 6, pp. 1077-1094
Open Access | Times Cited: 2
Anders Björklund, Bengt Mattsson
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 6, pp. 1077-1094
Open Access | Times Cited: 2
LRRK2 along the Golgi and lysosome connection: a jamming situation
Giovanni Piccoli, Mattia Volta
Biochemical Society Transactions (2021) Vol. 49, Iss. 5, pp. 2063-2072
Open Access | Times Cited: 15
Giovanni Piccoli, Mattia Volta
Biochemical Society Transactions (2021) Vol. 49, Iss. 5, pp. 2063-2072
Open Access | Times Cited: 15
DNL151, DNL201, and BIIB094: experimental agents for the treatment of Parkinson’s disease
Thomas Müller
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 9, pp. 787-792
Closed Access | Times Cited: 6
Thomas Müller
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 9, pp. 787-792
Closed Access | Times Cited: 6
Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effects
Philip Wing‐Lok Ho, Eunice Eun-Seo Chang, Chi-Ting Leung, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 9
Philip Wing‐Lok Ho, Eunice Eun-Seo Chang, Chi-Ting Leung, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 9
The function of Golgi apparatus in LRRK2-associated Parkinson’s disease
Yonghang Wei, Maher Un Nisa Awan, Li‐Ping Bai, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 5
Yonghang Wei, Maher Un Nisa Awan, Li‐Ping Bai, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 5
LRRK2 G2019S promotes the development of colon cancer via modulating intestinal inflammation
Yuhang Wang, Joyce Z. Gao, Taylor Sakaguchi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Yuhang Wang, Joyce Z. Gao, Taylor Sakaguchi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
A LRRK2 /dLRRK ‐mediated lysosomal pathway that contributes to glial cell death and DA neuron survival
Linfang Wang, Honglei Wang, Shuanglong Yi, et al.
Traffic (2022) Vol. 23, Iss. 10, pp. 506-520
Open Access | Times Cited: 8
Linfang Wang, Honglei Wang, Shuanglong Yi, et al.
Traffic (2022) Vol. 23, Iss. 10, pp. 506-520
Open Access | Times Cited: 8